dpp-4 inhibitors and glp-1 agonists receptor Pathway, Pharmacodynamics Dipeptidyl Peptidase (DPP)-IV Inhibitors with
Description
Chandel NS

For instance, GLP-1RAs were demonstrated to reduce the risk of cardiovascular events (5) by decreasing the blood pressure (6), improving microvascular function, and reducing inflammation (7)
New Drugs for Weight Loss: What Plan Sponsors Need to Know Learn about the new weight-loss drugs and get cost-management tips

Diabetes Care 2024;47(Suppl 1):S15878

Liraglutide injection
